We are live on ! Find out more
LAB icon

Standard BioTools
LAB

160 hedge funds and large institutions have $337M invested in Standard BioTools in 2025 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 47 increasing their positions, 45 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

142% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 12

39% more call options, than puts

Call options by funds: $68K | Put options by funds: $49K

10% more funds holding

Funds holding: 145 → 160 (+15)

9% more capital invested

Capital invested by funds: $308M → $337M (+$29M)

4% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 45

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1.29% less ownership

Funds ownership: 75.16% → 73.87% (-1.3%)

Holders
160
Holders Change
+15
Holders Change %
+10.34%
% of All Funds
2.11%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
29
Increased
47
Reduced
45
Closed
12
Calls
$68K
Puts
$49K
Net Calls
+$19K
Net Calls Change
+$75K

Top Buyers

Rank Fund Capital Flow
1
LFCM
Long Focus Capital Management
Puerto Rico
+$3.74M
2
MCO
MAK Capital One
New York
+$3.13M
3
KLP
Kent Lake PR
Puerto Rico
+$1.11M
4
Goldman Sachs
Goldman Sachs
New York
+$712K
5
RA
Royce & Associates
New York
+$706K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$4.97M
2
MFS
Mirabella Financial Services
United Kingdom
-$3.44M
3
Millennium Management
Millennium Management
New York
-$3.01M
4
TM
Tikvah Management
North Carolina
-$1.66M
5
Primecap Management
Primecap Management
California
-$381K
Name Holding Trade Value Shares
Change 		Change in
Stake
AB
126
Amalgamated Bank
New York
$13K – – –
PCA
127
Pallas Capital Advisors
Massachusetts
$12.3K -$2.29K -2,067 -17%
SCM
128
Sterling Capital Management
North Carolina
$9.7K +$4.51K +4,067 +101%
CSS
129
Cubist Systematic Strategies
Connecticut
$7.86K +$7.26K +6,551 New
VWA
130
VSM Wealth Advisory
Maryland
$6K – – –
BNP Paribas Asset Management
131
BNP Paribas Asset Management
France
$6K +$5.21K +4,700 New
Nisa Investment Advisors
132
Nisa Investment Advisors
Missouri
$5.43K -$258 -233 -5%
Raymond James Financial
133
Raymond James Financial
Florida
$4.66K +$4.3K +3,881 New
SOW
134
State of Wyoming
Wyoming
$3.34K +$3.08K +2,783 New
Comerica Bank
135
Comerica Bank
Texas
$3.27K +$369 +333 +14%
TWD
136
True Wealth Design
Ohio
$2.74K +$1.32K +1,190 +109%
BA
137
Bellwether Advisors
Nebraska
$2.42K – – –
CIAM
138
Caitong International Asset Management
Hong Kong
$2.32K +$2.14K +1,932 New
EP
139
Essential Partners
California
$2.25K +$2.08K +1,878 New
AUB
140
Atlantic Union Bankshares
Virginia
$2.1K +$1.94K +1,750 New
CIBC Private Wealth Group
141
CIBC Private Wealth Group
Georgia
$1.68K – – –
Osaic Holdings
142
Osaic Holdings
Arizona
$1.13K +$72 +65 +7%
IA
143
IFP Advisors
Florida
$982 +$908 +819 New
Russell Investments Group
144
Russell Investments Group
United Kingdom
$972 +$898 +810 New
SAM
145
Smartleaf Asset Management
Massachusetts
$938 -$2.8K -2,526 -76%
AF
146
Allworth Financial
California
$934 -$40 -36 -4%
NEWAS
147
N.E.W. Advisory Services
Wisconsin
$636 – – –
RA
148
Rise Advisors
New York
$556 +$513 +463 New
S
149
SignatureFD
Georgia
$380 -$5.38K -4,853 -94%
MCM
150
MAI Capital Management
Ohio
$360 – – –
3 4 5
6
7

LAB Hedge Fund Activity: Q2 2025 in Review

160 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q2 2025, worth a combined $337M — up 9.4% from $308M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new LAB positions and 12 closed out — a net gain of 17 holders — while 47 added to existing stakes and 45 trimmed.

The largest buyer was Long Focus Capital Management, adding an estimated $3.74M. The largest seller was Morgan Stanley, cutting an estimated $4.97M.

  • 160 institutional investors held Standard BioTools (LAB) as of Q2 2025, up from 145 in Q1 2025.
  • Funds reported $337M of Standard BioTools stock for Q2 2025, up 9.4% quarter-over-quarter.
  • 29 funds opened new Standard BioTools positions in Q2 2025 and 12 closed out, a net change of +17 holders.
  • The largest Standard BioTools buyer in Q2 2025 was Long Focus Capital Management, an estimated $3.74M added.
  • The largest Standard BioTools seller in Q2 2025 was Morgan Stanley, an estimated $4.97M sold.

Based on aggregated 13F filings for Q2 2025.